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Abstract
Background: The term ‘irritable nociceptor’ was coined to describe neuropathic
patients characterized by evoked hypersensitivity and preservation of primary
afferent fibres. Oxcarbazepine is largely ineffectual in an overall patient popula-
tion, but has clear efficacy in a subgroup with the irritable nociceptor profile. We
examine whether neuropathy in rats induced by spinal nerve injury shares over-
lapping pharmacological sensitivity with the irritable nociceptor phenotype using
drugs that target sodium channels.
Methods: In vivo electrophysiology was performed in anaesthetized spinal nerve
ligated (SNL) and sham‐operated rats to record from wide dynamic range (WDR)
neurones in the ventral posterolateral thalamus (VPL) and dorsal horn.
Results: In neuropathic rats, spontaneous activity in the VPL was substantially
attenuated by spinal lidocaine, an effect that was absent in sham rats. The former
measure was in part dependent on ongoing peripheral activity as intraplantar
lidocaine also reduced aberrant spontaneous thalamic firing. Systemic oxcarbazepine
had no effect on wind‐up of dorsal horn neurones in sham and SNL rats. However, in
SNL rats, oxcarbazepine markedly inhibited punctate mechanical‐, dynamic brush‐
and cold‐evoked neuronal responses in the VPL and dorsal horn, with minimal
effects on heat‐evoked responses. In addition, oxcarbazepine inhibited spontaneous
activity in the VPL. Intraplantar injection of the active metabolite licarbazepine repli-
cated the effects of systemic oxcarbazepine, supporting a peripheral locus of action.
Conclusions: We provide evidence that ongoing activity in primary afferent
fibres drives spontaneous thalamic firing after spinal nerve injury and that oxcar-
bazepine through a peripheral mechanism exhibits modality‐selective inhibitory
effects on sensory neuronal processing.
Significance: The inhibitory effects of lidocaine and oxcarbazepine in this rat
model of neuropathy resemble the clinical observations in the irritable nociceptor
patient subgroup and support a mechanism‐based rationale for bench‐to‐bedside
translation when screening novel drugs.
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1 | INTRODUCTION
Neuropathic pain remains poorly treated for the majority
of patients. Emerging evidence, largely from post hoc
analysis of clinical trial data, supports that sensory profil-
ing of neuropathic patients could improve patient out-
comes by targeting specific underlying mechanisms
(Bouhassira & Attal, 2016; Simpson et al., 2010; Yarnit-
sky, Granot, Nahman‐Averbuch, Khamaisi, & Granovsky,
2012). Rowbotham and Fields initially described two sen-
sory profiles in post‐herpetic neuralgia patients. The first
was largely characterized by sensory loss and ongoing
pain which was insensitive to local lidocaine infusion,
whereas in the second group severe allodynia was the
most prominent sensory disturbance, but in these cases
local lidocaine alleviated ongoing pain (Rowbotham &
Fields, 1989). The latter group is more commonly
described as the irritable nociceptor phenotype and the
former as non‐irritable/deafferentation‐type pain, although
the features of both sensory phenotypes can be present
within the same patient (Fields, Rowbotham, & Baron,
1998). Each phenotype may be determined by distinct
mechanisms which potentially provide unique opportuni-
ties for treatment.
Oxcarbazepine and carbamazepine are recommended as
front‐line treatments for trigeminal neuralgia (Cruccu et al.,
2008). In contrast, there is a paucity of reliable evidence
for efficacy in neuropathic patients with meta‐analyses con-
cluding minimal/no benefit compared to placebo (Wiffen,
Derry, Moore, & Kalso, 2014; Zhou et al., 2017). In pre‐
clinical models, the reported efficacy of carbamazepine,
and structurally related drugs, is variable and may relate to
the nature of the injury and/or endpoints used in these
investigations (Chapman, Suzuki, Chamarette, Rygh, &
Dickenson, 1998; Fox, Gentry, Patel, Kesingland, &
Bevan, 2003; Hunter et al., 1997; Jang, Kim, Park, Lee, &
Moon, 2005; Lau et al., 2013). In this study, we aimed to
back‐translate two clinical observations based on sensory
profiling providing preliminary evidence that patients with
the irritable nociceptor phenotype may benefit from the
anticonvulsant oxcarbazepine (Demant et al., 2014) and a
topical lidocaine patch against certain secondary pain mea-
sures (Demant et al., 2015). To this end, we examined the
effects of lidocaine and oxcarbazepine in the spinal nerve
ligation (SNL) model, which involves selective ligation and
injury of the L5 and L6 spinal nerves, and preservation of
L4 afferents.
In vivo electrophysiology was performed to determine
drug effects on sensory neuronal processing at the spinal
and thalamic levels. The lateral thalamic projection path-
way is crucial to the sensory‐discriminative dimension of
pain and is supported by electrophysiological and micro‐
stimulation studies in patients undergoing neurosurgical
procedures (Davis et al., 1999; Lee, Dougherty, Antezana,
& Lenz, 1999; Lenz et al., 1993; Ohara, Weiss, & Lenz,
2004). The fine‐tuned coding of spinothalamic wide
dynamic range (WDR) neurones accurately relates to the
ability to detect small differences in the intensity of nox-
ious stimuli (Dubner, Kenshalo, Maixner, Bushnell, &
Oliveras, 1989; Maixner, Dubner, Bushnell, Kenshalo, &
Oliveras, 1986), and following peripheral nerve injury in
rats WDR neurones in the VPL can exhibit evoked hyper-
excitability and elevated ongoing activity (Patel & Dicken-
son, 2016). Importantly, in parallel human and rodent
studies, the relationship between rat spinal WDR proper-
ties and human pain thresholds has also been described
(Coghill, Mayer, & Price, 1993; O'Neill, Sikandar, McMa-
hon, & Dickenson, 2015; Sikandar, Ronga, Iannetti, &
Dickenson, 2013). Hence, these characterizations represent
an objective and quantifiable neural substrate of sensory
function that overcomes many of the limitations of reflex-
ive endpoints.
2 | METHODS
2.1 | Animals
Sham or spinal nerve ligated (14–18 days post‐surgery) male
Sprague‐Dawley rats (250–300 g) were used for electrophys-
iological experiments (Biological Services, University Col-
lege London, UK). Animals were group‐housed (maximum
of 4) on a conventional 12:12‐hr light–dark cycle; food and
water were available ad libitum. Temperature (20–22°C) and
humidity (55%–65%) of holding rooms were closely regu-
lated. All procedures described here were approved by the
UK Home Office, adhered to the Animals (Scientific Proce-
dures) Act 1986 and were designed in accordance with ethics
guidelines outlined by the International Association for the
Study of Pain (Zimmermann, 1983).
2.2 | Spinal nerve ligation (SNL) surgery
Spinal nerve ligation surgery was performed as previously
described (Ho Kim & Mo Chung, 1992). Rats (130–140 g)
were maintained under 2% v/v isoflurane anaesthesia deliv-
ered in a 3:2 ratio of nitrous oxide and oxygen. Under
aseptic conditions a paraspinal incision was made and the
tail muscle excised. Part of the L5 transverse process was
removed to expose the left L5 and L6 spinal nerves, which
were then isolated with a glass nerve hook (Ski‐Ry, Lon-
don, UK) and ligated with a non‐absorbable 6–0 braided
silk thread proximal to the formation of the sciatic nerve.
The surrounding skin and muscle was closed with absorb-
able 4–0 sutures. Sham surgery was performed in an
2 | PATEL ET AL.
identical manner omitting the nerve isolation and ligation
step. All rats groomed normally and gained weight in the
following days post‐surgery.
2.3 | In vivo electrophysiology
2.3.1 | Thalamic recordings
Rats were initially anaesthetized with 3.5% v/v isoflurane
delivered in a 3:2 ratio of nitrous oxide and oxygen. Once
areflexic, a tracheotomy was performed and rats were sub-
sequently maintained on 1.5% v/v isoflurane for the remain-
der of the experiment (approximately 3–4 hr). Core body
temperature was maintained with the use of a homeothermic
blanket, and respiratory rate was visually monitored
throughout. Rats were secured in a stereotaxic frame, and
after the was the skull exposed, coordinates for the right
ventral posterolateral nucleus (VPL) of the thalamus (con-
tralateral to injury) were calculated in relation to bregma
(2.28 mm caudal, 3.2 mm lateral) (Watson & Paxinos,
2006). A small craniotomy was performed with a high‐
speed surgical micro‐drill. For spinal lidocaine experiments,
a partial laminectomy was performed to expose the L4‐L6
lumbar region and the overlying dura was removed. Extra-
cellular recordings were made from VPL thalamic neurones
with receptive fields on the glabrous skin of the left paw
hind toes (Supporting Information Figure S1 for stereotaxi-
cally determined recording sites) using 127‐μm‐diameter 2‐
MΩ parylene‐coated tungsten electrodes (A‐M Systems,
Sequim, WA). Searching involved light tapping of the hind
paw. Neurones were classified as wide dynamic range
(WDR) on the basis of neuronal sensitivity to dynamic
brushing (i.e. gentle stroking with a squirrel‐hair brush),
and noxious punctate mechanical (60 g) and heat (48°C)
stimulation of the receptive field. The receptive field was
then stimulated using a range of natural stimuli (brush, von
Frey filaments – 2, 8, 15, 26 and 60 g and heat – 35, 42, 45
and 48°C) applied over a period of 10 s per stimulus. The
heat stimulus was applied with a constant water jet onto the
centre of the receptive field. Acetone and ethyl chloride
(100 μl) were applied as an evaporative innocuous cooling
and noxious cooling stimulus, respectively (Leith, Kout-
sikou, Lumb, & Apps, 2010), and responses quantified over
10 s post‐application. Evoked responses to room tempera-
ture water (25°C) were minimal, or frequently completely
absent, and subtracted from acetone and ethyl chloride
evoked responses to control for any concomitant mechanical
stimulation during application. Stimuli were applied starting
with the lowest intensity stimulus with approximately 30–
40 s between stimuli in the following order: brush, von
Frey, cold and heat.
For lidocaine experiments, lidocaine hydrochloride
(Sigma, UK) was either applied directly to the dorsal
aspect of the spinal cord (20 μl, 10% w/v), or injected sub-
cutaneously into the receptive field (20 μl, 4% w/v). Spon-
taneous neuronal activity was quantified over a period of
60 s immediately prior to delivery of lidocaine and again
once complete block of evoked firing was confirmed. For
oxcarbazepine experiments, after obtaining baseline evoked
responses (mean of three trials), oxcarbazepine (Sigma,
UK) was injected subcutaneously into the right flank
(30 mg/kg, 1 ml/kg, vehicle: 85% normal saline, 10% Cre-
mophor, 5% DMSO) and neuronal responses to natural
stimuli were tested at 10, 30 and 50 min post‐dosing. The
drug dose was guided by a previous study (Jang et al.,
2005), and the effectiveness was confirmed in a pilot
experiment. For licarbazepine studies, licarbazepine (Tocris,
Abingdon, UK) was injected subcutaneously into the recep-
tive field (100 μg/20 μl, vehicle: 99% normal saline, 1%
DMSO) and neuronal responses to natural stimuli were
tested at 5 and 25 min post‐dosing; time point of peak
change is plotted for both spontaneous and evoked mea-
sures. An effective dose was determined on the basis of a
pilot experiment. For all intraplantar injections, the needle
was inserted adjacent to the receptive field to avoid direct
tissue damage.
Data were captured and analysed by a CED1401 inter-
face coupled to a computer with Spike2 v4 software (Cam-
bridge Electronic Design, Cambridge, United Kingdom).
The signal was amplified (×6000), band‐pass‐filtered (low‐/
high‐frequency cut‐off 1.5/2 kHz) and digitized at rate of
20 kHz. Spike sorting was performed post hoc with Spike2
using fast Fourier transform followed by three‐dimensional
principal component analysis of waveform feature measure-
ments for multi‐unit discrimination. Neurones were
recorded from one site per rat; one to three neurones were
characterized at each site. Stimulus‐evoked neuronal
responses were determined by subtracting total spontaneous
neuronal activity in the 10‐s period immediately preceding
stimulation. Spontaneous neuronal activity was measured
as follows. The single spike firing rate of individual neu-
rones (i.e. all stimulus‐independent neuronal events, includ-
ing those in bursts, expressed as mean number of spikes
per second) and the burst firing rate (number of bursts per
second) were determined over a period of 60 s in the
absence of stimulation as previously described (Hains,
Saab, & Waxman, 2006). Neuronal events were considered
as bursts based on the following parameters: maximum ini-
tial interval signifying burst onset (6 ms), longest interspike
interval allowed within burst (9 ms) and minimum number
of events in a burst (2).
2.3.2 | Dorsal horn recordings
Rats were anaesthetized as described above (2.3.1) and
secured in a stereotaxic frame, and a laminectomy was
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performed to expose L4‐L6 segments of the spinal cord.
Extracellular recordings were made from deep dorsal horn
WDR lamina V/VI neurones with receptive fields on the
glabrous skin of the left hind toes. Non‐spontaneously
active neurones were selected to allow accurate determina-
tion and separation of electrically evoked spikes. The neu-
ronal depth, from the surface of the spinal cord, was
determined stereotaxically. All recordings were made at
depths delineating the deep dorsal horn laminae (Watson,
Paxinos, Kayalioglu, & Heise, 2009). For all spinal experi-
ments, one neurone was recorded per rat.
Electrical stimulation of WDR neurones was delivered
transcutaneously via needles inserted into the receptive
field. A train of 16 electrical stimuli (2‐ms pulses, 0.5 Hz)
was applied at three times the threshold current for C‐fibre
activation. Responses evoked by Aβ‐ (0–20 ms), Aδ‐ (20–
90 ms) and C‐fibres (90–300 ms) were separated and quan-
tified on the basis of latency. Neuronal responses occurring
after the C‐fibre latency band were classed as post‐dis-
charge (PD). The input (I) and the wind‐up (WU) were cal-
culated as follows: Input = (action potentials evoked by
first pulse) × total number of pulses (16); wind‐up = (total
action potentials after 16 train stimulus) ‐ Input. The recep-
tive field was also stimulated using a range of natural stim-
uli (see section 2.3.1). After three consecutive stable
baseline responses to electrical and natural stimuli (<10%
variation, data were averaged to give control values),
30 mg/kg oxcarbazepine (Sigma, UK) or vehicle (85% nor-
mal saline, 10% Cremophor, 5% DMSO) were injected sub-
cutaneously into the right flank. Neuronal responses to
electrical and natural stimuli were tested at 10, 30 and
50 min post‐dosing; time point of peak change is plotted.
A total of 5 naïve, 12 sham and 33 SNL rats were used in
this study. All electrophysiological studies were non‐recov-
ery; after the last post‐drug time point, rats were termi-
nally anaesthetized with isoflurane followed by cervical
dislocation.
2.4 | Statistics
Statistical analyses were performed using SPSS, version 25
(IBM, Armonk, NY). Heat coding and mechanical coding
of neurones were compared with a two‐way repeated‐mea-
sures (RM) ANOVA, followed by a Bonferroni post hoc
test for paired comparisons. Where appropriate, sphericity
was tested using Mauchly's test; the Greenhouse–Geisser
correction was applied if violated. Cold, brush and single
spike/burst firings were compared with a two‐tailed paired
Student's t‐test. Group sizes were determined by a priori
calculations (α 0.05, 1‐β 0.8). All data represent mean ±
95% confidence interval (CI). *p < 0.05, **p < 0.01,
***p < 0 .001.
3 | RESULTS
3.1 | Systemic oxcarbazepine inhibits
spinal neuronal responses in SNL but not
sham rats
In vivo electrophysiology was performed in the dorsal
horn to validate the inhibitory effect of oxcarbazepine in
the SNL model. After stable baselines were obtained,
sham and SNL rats were dosed subcutaneously with
30 mg/kg oxcarbazepine. In sham‐operated rats, oxcar-
bazepine displayed no inhibitory effect on punctate
mechanical‐ (Figure 1a) (two‐way RM ANOVA
F1,6 = 0.58, p = 0.818), heat‐ (Figure 1b) (two‐way RM
ANOVA F1,6 = 0.48, p = 0.514), evaporative cooling‐
(Figure 1c) (paired Student's t‐test, acetone: p = 0.732;
ethyl chloride: p = 0.418) or dynamic brush‐evoked firing
(Figure 1d) (paired Student's t‐test, p = 0.143). In contrast,
a marked inhibitory effect was observed in SNL rats. We
found strong evidence for reduced neuronal responses to
low‐intensity (2 and 8 g) and noxious (15, 26 and 60 g)
punctate mechanical stimuli post‐dosing (Figure 1e) (two‐
way RM ANOVA F1,7 = 112.637, p = 0.000014). How-
ever, only weak evidence was found for a reduction in
heat‐evoked responses (Figure 1f) (two‐way RM ANOVA
F1,7 = 7.362, p = 0.0301, paired comparisons p > 0.05).
Both innocuous (acetone) and noxious (ethyl chloride)
evaporative cooling stimuli evoked fewer spikes post‐
dosing (Figure 1g) (paired Student's t‐test, acetone:
p = 0.0072; ethyl chloride: p = 0.0103). In addition,
oxcarbazepine inhibited neuronal responses to dynamic
brushing of the receptive field (Figure 1h) (paired Stu-
dent's t‐test, p = 0.0118).
Neuronal responses to repetitive stimulation were also
quantified. After a sequence of supra‐threshold electrical
stimuli, the total number of action potentials attributed to
Aβ‐, Aδ‐, and C‐fibres did not differ from baseline in
FIGURE 1 Oxcarbazepine selectively inhibits spinal neuronal responses in SNL rats in a modality‐dependent manner. Lamina V/VI WDR
neuronal responses to punctate mechanical (a), heat (b), cold (c) and dynamic brush (d) stimuli prior to and following systemic administration of
oxcarbazepine (30 mg/kg) in sham rats (n = 7). Neuronal responses to punctate mechanical (e), heat (f), cold (g) and dynamic brush (h) stimuli
prior to and following systemic administration of oxcarbazepine in SNL rats (n = 8). Histogram traces represent typical single‐unit responses.
Data represent mean ± 95% CI. Asterisks (*) denote difference from baseline; *p < 0.05, **p < 0.01, ***p < 0.001. (Ac, acetone; Ec, ethyl
chloride)
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either sham (Figure 2a) (paired Student's t‐test: Aβ‐fibres,
p = 0.059; Aδ‐fibres, p = 0.461; C‐fibres, p = 0.768) or
SNL rats (Figure 2b) (paired Student's t‐test: Aβ‐fibres,
p = 0.307; Aδ‐fibres, p = 0.077; C‐fibres, p = 0.383).
Measures of neuronal excitability, input (the non‐poten-
tiated response), wind‐up (potentiated response) and post‐
discharge were also unaffected in both sham (paired Stu-
dent's t‐test: input, p = 0.983; wind‐up, p = 0.453; post‐
discharge, p = 0.297) (Figure 2a) and SNL rats (paired
Student's t‐test: input, p = 0.628; wind‐up, p = 0.843;
post‐discharge, p = 0.863) (Figure 2b). The vehicle alone
had no effect on either stimulus‐evoked or electrically
evoked neuronal responses in naïve rats (Supporting Infor-
mation Figure S2).
3.2 | Aberrant spontaneous neuronal activity
in the VPL of neuropathic rats is driven by
peripheral and spinal events
We next examined integrative sensory processing in
ascending pathways receiving convergent spinal output.
Baseline evoked responses and spontaneous activity (Sup-
porting Information Figure S3) were comparable to our
previous observations (Patel & Dickenson, 2016; Patel, Qu,
Xie, Porreca, & Dickenson, 2018). Spinally delivered lido-
caine induced a complete block of evoked activity (tested
with 60 g von Frey). Following confirmation of spinal
block, in sham‐operated rats, the single spike firing rate
(Figure 3a) (paired Student's t‐test, p = 0.441) and burst
firing rate (Figure 3b) (paired Student's t‐test, p = 0.155)
were unaffected demonstrating the absence of tonic spinal
activity converging onto thalamic WDR neurones under
normal conditions. In contrast, in SNL rats, spinal lidocaine
substantially reduced the single spike firing rate (Figure 3c)
(paired Student's t‐test, p = 0.0001) and burst firing rate
(Figure 3d) (paired Student's t‐test, p = 0.0053) in all char-
acterized neurones. Furthermore, we found evidence that
local block of the receptive field also reduced the single
spike firing rate (Figure 3e) (paired Student's t‐test,
p = 0.0123) and burst firing rate of WDR neurones (Fig-
ure 3f) (paired Student's t‐test, p = 0.0445), although nota-
bly the effect size was greater with the spinal route of
dosing for both these measures of spontaneous activity
(single spike rate – spinal: Cohen's d = 1.10, intraplantar:
Cohen's d = 0.64; burst rate – spinal: Cohen's d = 0.79,
intraplantar: Cohen's d = 0.54).
3.3 | Oxcarbazepine inhibits spontaneous and
stimulus‐evoked neuronal activity in the VPL
of neuropathic rats acting via a peripheral
mechanism
The inhibitory effects of oxcarbazepine on stimulus‐evoked
thalamic neuronal responses in SNL rats were comparable
FIGURE 2 Oxcarbazepine does not inhibit wind‐up of lamina V/VI WDR neurones in either sham or SNL rats. Total neuronal events,
separated according to latency, following repeated electrical stimulation in sham (a) and SNL rats (b), prior to and following systemic
administration of oxcarbazepine (30 mg/kg); input and wind‐up calculated as described in Materials and Methods. Waveform traces represent
typical single‐unit responses. Data represent mean ± 95% CI; sham: n = 7, SNL: n = 8. (PD, post‐discharge; I, input, WU, wind‐up)
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to the effects observed on spinal neurones. Systemic oxcar-
bazepine (30 mg/kg) inhibited neuronal responses to punc-
tate mechanical stimuli (Figure 4a) (two‐way RM ANOVA
F1,8 = 12.413, p = 0.0078), had no effect on heat‐evoked
responses (Figure 4b) (two‐way RM ANOVA F1,8 = 2.96,
p = 0.124) and inhibited noxious cold‐evoked (ethyl chlo-
ride) responses (Figure 4c) (paired Student's t‐test, acetone:
p = 0.407; ethyl chloride: p = 0.0094) and brush‐evoked
responses (Figure 4d) (paired Student's t‐test, p = 0.0029).
In addition, spontaneous activity, that is the single spike
firing rate (Figure 4e) (paired Student's t‐test, p = 0.0014)
and burst firing rate (Figure 4f) (paired Student's t‐test,
p = 0.0117), was reduced post‐dosing in 7/9 units tested.
As oxcarbazepine is a pro‐drug that undergoes hepatic
conversion, we next examined the effects of injecting the
active metabolite, licarbazepine, directly into the receptive
field of SNL rats to identify any peripheral mechanisms of
action. Compared to systemic oxcarbazepine, intraplantar
licarbazepine (100 μg/20 μl) exerted identical modality‐
selective inhibitory effects. Licarbazepine inhibited neu-
ronal responses to punctate mechanical stimuli (Figure 5a)
(two‐way RM ANOVA F1,9 = 25.887, p = 0.00066) and
was without effect on heat‐evoked responses (Figure 5b)
(two‐way RM ANOVA F1,8 = 1.23, p = 0.296). Licar-
bazepine reduced noxious cold‐evoked responses (ethyl
chloride), and weak evidence was found for similar effects
FIGURE 3 Spinal lidocaine and intraplantar lidocaine selectively attenuate spontaneous firing of thalamic WDR neurones in SNL rats.
Single spike (a) and burst (b) firing rates in sham rats (n = 9 neurones from 5 rats) prior to and post‐spinal delivery of lidocaine (10% w/v,
20 μl). Single spike (c) and burst (d) firing rates in SNL rats (n = 11 neurones from 6 rats) prior to and post‐spinal delivery of lidocaine (10%
w/v, 20 μl). Single spike (e) and burst (f) firing rates in SNL rats (n = 9 neurones from 5 rats) prior to and post‐intraplantar injection of
lidocaine (4% w/v, 20 μl). Histogram and event mark traces represent typical single‐unit responses. Event markers (EM) indicate the time point
of spike upstroke, and burst markers (BM) signify individual burst events. Data represent mean ± 95% CI. Asterisks (*) denote difference from
baseline; *p < 0.05, **p < 0.01, ***p < 0.001
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in response to innocuous evaporative cooling (acetone)
(Figure 5c) (paired Student's t‐test, acetone: p = 0.06; ethyl
chloride: p = 0.00186). In addition, dynamic brush‐evoked
neuronal responses were inhibited (Figure 5d) (paired Stu-
dent's t‐test, p = 0.0059). Licarbazepine attenuated the sin-
gle spike firing rate in 7/10 units tested (Figure 5e) (paired
Student's t‐test, p = 0.0102), but only weak evidence was
found for a decrease in the burst firing rate (Figure 5f)
(paired Student's t‐test, p = 0.0531). No drug effects were
observed on the number of spikes per burst, burst
interspike interval or burst length (Supporting Information
Table S1).
4 | DISCUSSION
Herein we describe the pathophysiological state‐dependent
and modality‐selective effects of the anticonvulsant
drug oxcarbazepine on stimulus‐evoked and stimulus‐inde-
pendent central sensory neuronal excitability in vivo. To
FIGURE 4 Oxcarbazepine inhibits stimulus‐evoked and spontaneous firing of thalamic WDR neurones in SNL rats. Neuronal responses to
punctate mechanical (a), heat (b), cold (c), dynamic brush (d) stimuli, and spontaneous single spike (e) and burst (f) firing rates, prior to and
following systemic administration of oxcarbazepine (30 mg/kg). Histogram and event mark traces represent typical single‐unit responses. Event
markers (EM) indicate the time point of spike upstroke, and burst markers (BM) signify individual burst events. Data represent mean ± 95% CI,
n = 9 neurones from 7 rats. Asterisks (*) denote difference from baseline; *p < 0.05, **p < 0.01. (Ac, acetone; Ec, ethyl chloride)
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our knowledge, this study for the first time reports that ele-
vated spontaneous thalamic firing in the SNL model is
dependent on ongoing peripheral activity.
Oxcarbazepine is a keto analogue of carbamazepine;
both are generally considered to act in a similar manner
primarily as non‐selective blockers of sodium channels, but
actions on potassium and calcium channels have also been
reported (Ambrosio, Soares‐Da‐Silva, Carvalho, & Car-
valho, 2002). Primary afferent fibres can express the TTX‐
S channels Nav1.1, 1.6 and 1.7, and TTX‐R channels
Nav1.8 and 1.9 (Dib‐Hajj, Cummins, Black, & Waxman,
2010); both TTX‐S and TTX‐R currents are sensitive to
inhibition by carbamazepine in vitro (Rush & Elliott,
1997). These actions are via binding to inactivated sodium
channels, slowing recovery into the resting state and
thereby limiting channels available for opening (Hebeisen
et al., 2015). Like lacosamide, carbamazepine binds to slow
inactivated channels and this activation state may be asso-
ciated with prolonged depolarizations that can occur in epi-
lepsy and neuropathic pain (Cardenas, Cardenas, de
FIGURE 5 Intraplantar licarbazepine replicates the inhibitory effects of systemic oxcarbazepine on thalamic neuronal excitability in SNL
rats. WDR neuronal responses to punctate mechanical (a), heat (b), cold (c), dynamic brush (d) stimuli, and spontaneous single spike (e) and
burst (f) firing rates, prior to and following intraplantar injection of licarbazepine (100 μg/20 μl). Histogram and event mark traces represent
typical single‐unit responses. Event markers (EM) indicate the time point of spike upstroke, and burst markers (BM) signify individual burst
events. Data represent mean ± 95% CI, n = 10 neurones from 7 rats. Asterisks (*) denote difference from baseline; *p < 0.05, ***p < 0.001.
(Ac, acetone; Ec, ethyl chloride)
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Armendi, & Scroggs, 2006; Sheets, Heers, Stoehr, & Cum-
mins, 2008). The inhibitory effects of carbamazepine are
enhanced at depolarized holding potentials (Kuo, Chen, Lu,
& Chen, 1997), and high‐frequency firing superimposed
onto the background of altered membrane excitability may
be favoured in the irritable nociceptor phenotype and
trigeminal neuralgia. Intriguingly, the V400M gain‐of‐func-
tion point mutation of Nav1.7 that causes erythromelalgia
can confer sensitivity to carbamazepine and provides
insight into how the biophysical properties of sodium chan-
nel function could influence drug sensitivity in patients
(Fischer et al., 2009).
The modality‐selective inhibitions exerted by oxcar-
bazepine (i.e. brush, punctate mechanical and cold) impli-
cate a prominent role of Nav1.7, 1.8 and 1.9 channels in
mediating these effects. Nav1.8 is predominantly expressed
in nociceptors, but also a subset of non‐nociceptive affer-
ents which could relay low‐intensity tactile information
(Djouhri et al., 2003). Genetic deletion of Nav1.8 (Akopian
et al., 1999; Matthews, Wood, & Dickenson, 2006), or
pharmacological block (Patel, Brice, Lewis, & Dickenson,
2015), impairs behavioural and neuronal responses to punc-
tate mechanical stimuli, but heat sensitivity is less affected.
Ablating expression of Nav1.7 in sensory afferents pro-
duces deficits in noxious mechanical, heat and innocuous
cold sensitivity (Minett, Eijkelkamp, & Wood, 2014;
Minett et al., 2012). In addition, Nav1.8 and 1.9 are inte-
gral to noxious cold sensitivity (Lolignier et al., 2015; Zim-
mermann et al., 2007). Oxcarbazepine had no overall effect
on Aβ‐, Aδ‐, and C‐fibre‐evoked responses of lamina V/VI
neurones following electrical stimulation of the receptive
field. The supra‐threshold and synchronized nature of the
stimulus may be less amenable to inhibition compared to
the prolonged activation at threshold levels of stimulation
with natural stimuli. The absence of drug effects on post‐
synaptically mediated potentiation perhaps indicates greater
alterations in the biophysical properties of sodium channel
function in primary afferents rendering second‐order neu-
rones less susceptible to inhibition. The modality‐selective
inhibitory effects are consistent with a pre‐synaptic mecha-
nism (in peripheral and/or central terminals) as direct inhi-
bition of post‐synaptic excitability by oxcarbazepine would
reduce neuronal excitability to all peripheral inputs across
sensory modalities and intensities. The absence of effect on
wind‐up potentiation also argues against direct actions on
spinal neurones.
Distinct roles for injured and uninjured afferents have
been proposed in relation to evoked and spontaneous fea-
tures of neuropathy in rats (Li, Dorsi, Meyer, & Belzberg,
2000; Yoon, Na, & Chung, 1996). After peripheral nerve
injury both injured and neighbouring intact neurones exhi-
bit increased membrane excitability and spontaneous activ-
ity, mediated in part by altered expression and distribution
of voltage‐gated sodium channels (Black et al., 1999; Bou-
cher et al., 2000; Decosterd, Ji, Abdi, Tate, & Woolf,
2002; Gold et al., 2003; Hains, Saab, Klein, Craner, &
Waxman, 2004; Kim, Oh, Chung, & Chung, 2002; Ma et
al., 2003; Wu et al., 2001; Zhao, Waxman, & Hains,
2006). Dorsal horn neurones in this study exhibited mini-
mal spontaneous activity, consistent with previous charac-
terizations reporting aberrant spontaneous firing in a subset
of innervated neurones in SNL rats (Chapman, Suzuki, &
Dickenson, 1998). An important consideration in reconcil-
ing the dorsal horn and thalamic neuronal properties is that
dorsal horn neurones without peripheral receptive fields
can be spontaneously active (Dalal et al., 1999; Suzuki &
Dickenson, 2006), and an element of this ongoing activity
could originate from the neuromas at L5 and L6. Thus, the
summation of this spinal activity converges onto thalamic
pathways. Local and spinal block with lidocaine reveals
evidence of ongoing activity within ascending sensory pro-
jection pathways in the SNL model, and notably the inhibi-
tory effect was greater following spinal block. However,
we cannot infer from this observation alone whether this
reflects noxious input to the thalamus, nor can we deter-
mine whether the effect of oxcarbazepine on this elevated
activity is primarily due to actions on injured or uninjured
primary afferents. Peripheral nerve block and intrathecal
lidocaine can produce conditioned place preference after
nerve or tissue injury, indicating relief from ongoing pain
(He, Tian, Hu, Porreca, & Wang, 2012; Navratilova et al.,
2012), and this could occur independently of activity
within the lateral ascending pathway (Navratilova et al.,
2015).
Direct evidence for actions of carbamazepine on injured
nerves came from demonstrations that systemic administra-
tion blocked ectopic firing in some transected afferents
(Burchiel, 1988; Yates, Smith, & Robinson, 2005). The
data presented here additionally identify inhibitory drug
effects on spontaneous peripheral activity distal to the
injury. The systemic dose of oxcarbazepine was more
effective at reducing spontaneous activity compared to the
local injection of licarbazepine. This difference may arise
from systemic drug actions at the level of the injury as sup-
ported by the aforementioned studies in neuromas, or by
inhibiting ectopic events that originate in dorsal root gan-
glion neurones (Wall & Devor, 1983), or by direct actions
within thalamocortical circuits. Thalamic neuronal
excitability is governed by feedback from cortical regions
and the thalamic reticular nucleus (TRN), which modulate
ascending sensory transmission (Monconduit, Lopez‐Avila,
Molat, Chalus, & Villanueva, 2006; Yen & Shaw, 2003).
GABAergic inputs from the TRN can promote burst firing
patterns (Cope, Hughes, & Crunelli, 2005), and the
decrease in the burst firing rate observed with intraplantar
lidocaine, and to some extent with intraplantar
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licarbazepine, is consistent with altered top‐down modula-
tion of thalamic neuronal excitability. However, with the
systemic dose of oxcarbazepine, inhibitory effects directly
on thalamic neurones and/or within these modulatory cir-
cuits are also possible.
Recently, a call has been reiterated to apply a sensory
profiling approach to animal models (Baron & Dickenson,
2014; Rice, Finnerup, Kemp, Currie, & Baron, 2018); that
is, models could be classified according to their sensory
gain/loss akin to quantitative sensory testing (QST) in
patients and drug effects should be determined against
these sensory endpoints. Fundamentally, there are chal-
lenges in aligning perceptual outcomes in patients with
measures in animals, but we provide an example of how a
sensory profile can in part be achieved in the SNL model
from thalamic neuronal recordings. Like many animal mod-
els, spinal nerve injury results in sensory gain across
modalities rather than sensory loss (Figure 6A) and shares
some resemblance to the ‘thermal’ phenotype (Baron et al.,
2017). Baron and colleagues note that the irritable nocicep-
tor patients are represented by the ‘thermal’ phenotype
based on proposed peripheral sensitization, yet cluster 3
with mechanical hyperalgesia are suggested to have central
sensitization. The sensory profile of the irritable nociceptor
phenotype could result from abnormal peripheral inputs,
but also from normal inputs impinging on a sensitized
spinal cord. Our data indicate that SNL rats appear to over-
lap with both these clusters and are very different from the
‘sensory loss’ group. By normalizing the effect size, the
inhibitory effect of oxcarbazepine in SNL rats is greatest
against noxious cold and punctate mechanical stimuli (Fig-
ure 6b). As these are sensory modalities tested with QST,
these observations could help shape translational studies
and test the validity of applying a sensory profiling
approach to pre‐clinical and clinical research.
These data support a reconsideration of how animal
models are utilized for screening novel drugs. The homo-
geneity of animal models complicates the translation of
pre‐clinical findings to patient groups exhibiting heteroge-
neous symptoms. Sensory profiles may represent a surro-
gate for underlying mechanisms (Baron et al., 2017;
Bouhassira & Attal, 2016; Truini, Garcia‐Larrea, & Cruccu,
2013), and a mechanism‐based approach would represent a
progressive way to link animal and clinical research (for
example see (Yarnitsky et al., 2012) and (Bannister, Patel,
Goncalves, Townson, & Dickenson, 2015)). Attempts to
correlate lidocaine sensitivity to sensory profiles have not
always proved successful (Haroutounian et al., 2014),
although patients with the irritable nociceptor phenotype
were more likely to achieve relief from a 5% lidocaine
patch against pain paroxysms and deep pain (Demant et al.,
2015). Intravenous lidocaine in peripheral neuropathy
patients alleviated ongoing pain and mechanical allodynia
without affecting thermal allodynia (Attal, Rouaud, Bras-
seur, Chauvin, & Bouhassira, 2004). Moreover, the degree
of relief was inversely correlated with deficits in thermal
sensitivity much like the early reports of the irritable noci-
ceptor phenotype (Attal et al., 2004; Rowbotham & Fields,
1989). With regard to oxcarbazepine, NNT values (3.9 and
13, respectively) are improved in the irritable versus non‐
irritable group (Demant et al., 2014). In this study, we
observe that oxcarbazepine, largely ineffectual in the
majority of neuropathic patients, exerts inhibitory effects in
the SNL model. It is conceivable that the failure to trans-
late the pre‐clinical effects of other state‐dependent ion
channel blockers (e.g. lacosamide (Beyreuther, Callizot, &
Stohr, 2006; Hearn, Derry, & Moore, 2012)) to clinical
FIGURE 6 A standardized representation of sensory gain in the
spinal nerve ligation model in rats (a). Historical neuronal data from
the ventral posterolateral thalamus were compiled from sham/naïve
(n = 84 neurones from 52 rats) and SNL rats (n = 111 neurones from
76 rats) to determine ‘normal’ levels of sensory coding and the
normalized degree of sensory gain in SNL rats. Wind‐up was
determined by collating historical data from dorsal horn recordings
from sham/naïve (n = 66 neurones from 66 rats) and SNL rats
(n = 61 neurones from 61 rats). Positive values represent gain‐of‐
function, and negative values represent loss‐of‐function compared to
the sham/naïve group (reproduced from Dickenson & Patel, 2018).
The standardized inhibitory profile of oxcarbazepine in SNL rats (b),
based on the thalamic and dorsal horn (WU‐only) neuronal responses
(pre‐ and post‐dosing comparison). Positive values represent
facilitation, and negative values represent inhibitory drug effects.
(Measures represent: B, brush; LTM, low‐threshold punctate
mechanical (2 g); HTM, high‐threshold punctate mechanical (60 g);
IC, innocuous cooling (acetone), NC, noxious cooling (ethyl
chloride); W, warm temperature (35°C); NH, noxious heat (48°C);
WU, wind‐up. Interconnecting lines indicate modality groups)
PATEL ET AL. | 11
efficacy has stemmed from poor trial design that lacks
stratification, and hence the sensitivity to determine posi-
tive drug effects in patient subgroups.
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